![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Apoptosis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via
m6A-dependent ferroptosis regulation.
Apoptosis. 2023 Jan 31. doi: 10.1007/s10495-023-01817.
PubMed
Abstract available
Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in
Women Undergoing Radical Cystectomy.
Arch Pathol Lab Med. 2023;147:202-207.
PubMed
Abstract available
Treatment trends of muscle invasive bladder cancer: Evidence from the
Surveillance, Epidemiology, and End Results database, 1988 to 2013.
Asian J Urol. 2023;10:9-18.
PubMed
Abstract available
Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in
bladder cancer.
Asian Pac J Cancer Prev. 2023;24:121-131.
PubMed
Abstract available
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous
bladder cancer.
BMC Cancer. 2023;23:113.
PubMed
Abstract available
IGF2BP3 overexpression predicts poor prognosis and correlates with immune
infiltration in bladder cancer.
BMC Cancer. 2023;23:116.
PubMed
Abstract available
A prognostic model based on necroptosis-related genes for prognosis and therapy
in bladder cancer.
BMC Urol. 2023;23:10.
PubMed
Abstract available
Penoscrotal oedema as the first sign of metastatic urothelial bladder cancer.
BMJ Case Rep. 2023;16:e254106.
PubMed
Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics.
Clin Cancer Res. 2023;29:581-591.
PubMed
Abstract available
Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal
Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint
Inhibitors.
Clin Genitourin Cancer. 2023;21:136-145.
PubMed
Abstract available
Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial
Carcinoma Treated with Pembrolizumab.
Clin Genitourin Cancer. 2023;21:128-135.
PubMed
Abstract available
Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced
Urothelial Carcinoma-A Cost-Effectiveness Analysis.
Clin Genitourin Cancer. 2023;21:8-15.
PubMed
Abstract available
DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper
Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Clin Genitourin Cancer. 2023;21:32-42.
PubMed
Abstract available
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial
Carcinoma Receiving Immune Checkpoint Inhibitors.
Clin Genitourin Cancer. 2023;21:69-75.
PubMed
Abstract available
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
Clin Genitourin Cancer. 2023;21:84-90.
PubMed
Abstract available
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of
Patients With Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00261.
PubMed
Abstract available
Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that
control lysosome positioning in the bladder cancer model.
Commun Biol. 2023;6:114.
PubMed
Abstract available
Comput Methods Programs Biomed
Gold nanorods assisted photothermal therapy of bladder cancer in mice: A
computational study on the effects of gold nanorods distribution at the centre,
periphery, and surface of bladder cancer.
Comput Methods Programs Biomed. 2023;230:107363.
PubMed
Abstract available
En-bloc resection of non-muscle invasive bladder cancer: does it really make a
difference?
Curr Opin Urol. 2023;33:147-151.
PubMed
Abstract available
Robotic radical cystectomy - more precision needed?
Curr Opin Urol. 2023;33:157-162.
PubMed
Abstract available
Performance of Multiple Imputation Using Modern Machine Learning Methods in
Electronic Health Records Data.
Epidemiology. 2023;34:206-215.
PubMed
Abstract available
A model for predicting overall survival in bladder cancer patients with signet
ring cell carcinoma: a population-based study.
Eur J Med Res. 2023;28:61.
PubMed
Abstract available
M7G-related molecular subtypes can predict the prognosis and correlate with
immunotherapy and chemotherapy responses in bladder cancer patients.
Eur J Med Res. 2023;28:55.
PubMed
Abstract available
DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
Eur Surg Res. 2022;63:155-164.
PubMed
Abstract available
Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is
as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral
Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder
Tumors. A P
Eur Urol. 2023;83:125-130.
PubMed
Abstract available
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial
Carcinomas Predict Response to Immune Checkpoint Inhibition.
Eur Urol. 2023;83:133-142.
PubMed
Abstract available
Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe
Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical
Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year
Median Foll
Eur Urol. 2023 Jan 25:S0302-2838(23)00021-0. doi: 10.1016/j.eururo.2023.
PubMed
Reply to Benjamin Pradere, Giuseppe Basile, and Thomas Seisen's Letter to the
Editor re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars
Dyrskjot, Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term,
Intensive Chem
Eur Urol. 2023 Jan 27:S0302-2838(23)00023-4. doi: 10.1016/j.eururo.2023.
PubMed
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG)
or External Beam Radiation Therapy in Patients with BCG-unresponsive
Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243
ADAPT-BLADDER Study.
Eur Urol. 2023 Jan 28:S0302-2838(23)00025-8. doi: 10.1016/j.eururo.2023.
PubMed
Abstract available
Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjot,
Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive
Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary
Outcome of a
Eur Urol. 2023 Jan 28:S0302-2838(23)00024-6. doi: 10.1016/j.eururo.2022.
PubMed
Re: Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in
Patients with Intermediate-risk Non-muscle invasive Bladder Cancer (HIVEC-II): A
Phase 2, Open-label, Randomised Controlled Trial.
Eur Urol. 2023 Jan 27:S0302-2838(23)00014-3. doi: 10.1016/j.eururo.2023.
PubMed
Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells.
Front Chem. 2023;11:1121724.
PubMed
Abstract available
TERT promoter mutations and methylation for telomerase activation in urothelial
carcinomas: New mechanistic insights and clinical significance.
Front Immunol. 2023;13:1071390.
PubMed
Abstract available
The different predictive value of mean platelet volume-to-lymphocyte ratio for
postoperative recurrence between non-muscular invasive bladder cancer patients
treated with intravesical chemotherapy and intravesical chemohyperthermia.
Front Oncol. 2023;12:1101830.
PubMed
Abstract available
Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker
for bladder cancer staging and prognosis.
Front Oncol. 2023;12:1102392.
PubMed
Abstract available
Construction and prognostic value of enhanced CT image omics model for
noninvasive prediction of HRG in bladder cancer based on logistic regression and
support vector machine algorithm.
Front Oncol. 2023;12:966506.
PubMed
Abstract available
Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic
electrocautery for the transurethral resection of non-muscle invasive bladder
cancer: The protocol and result of a multicenter randomized controlled trial.
Front Oncol. 2023;12:1065735.
PubMed
Abstract available
Predictive nomograms for early death in metastatic bladder cancer.
Front Surg. 2023;9:1037203.
PubMed
Abstract available
A prognostic cuproptosis-related lncRNA predictive signature for bladder cancer
patients.
Hum Cell. 2023 Jan 29. doi: 10.1007/s13577-023-00863.
PubMed
Abstract available
ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via
beta-catenin signaling and enhances mitomycin C sensitivity.
Hum Cell. 2023 Jan 30. doi: 10.1007/s13577-023-00860.
PubMed
Abstract available
Biological and prognostic implications of biopsy upgrading for high-grade upper
tract urothelial carcinoma at nephroureterectomy.
Int J Urol. 2023;30:63-69.
PubMed
Abstract available
Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node
or Metastatic Disease?
J Gastrointest Cancer. 2023 Feb 2. doi: 10.1007/s12029-023-00914.
PubMed
Abstract available
Correction: Intravesical BCG in patients with non-muscle invasive bladder cancer
induces trained immunity and decreases respiratory infections.
J Immunother Cancer. 2023;11:e005518corr1.
PubMed
Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor
After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer.
J Inflamm Res. 2023;16:283-296.
PubMed
Abstract available
Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the
AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell
Line.
J Oncol. 2023;2023:2830306.
PubMed
Abstract available
Retracted: Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated
with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and
Overall Survival in Patients with Bladder Cancer.
Med Sci Monit. 2023;29:e939596.
PubMed
Abstract available
Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients
Scheduled for Open Radical Cystectomy.
Med Sci Sports Exerc. 2023 Feb 2. doi: 10.1249/MSS.0000000000003137.
PubMed
Abstract available
[Photodynamic-guided transurethral resection: Uncertainties brought to light].
Prog Urol. 2023;33:56-57.
PubMed
Abstract available
Aloperine Prevents Migration, Invasion, and Adhesion by Upregulating TIMP-4 in
Human Bladder Cancer Cells.
Protein Pept Lett. 2023 Jan 24. doi: 10.2174/0929866530666230124112754.
PubMed
Abstract available
Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder
Cancer.
Rep Biochem Mol Biol. 2022;11:411-420.
PubMed
Abstract available
Androgen receptor-dependent regulation of metabolism in high grade bladder cancer
cells.
Sci Rep. 2023;13:1762.
PubMed
Abstract available
Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and
cancer stem cells (CSCs) characterization and to predict the prognosis and
immunotherapy response in bladder urothelial carcinoma.
Stem Cell Res Ther. 2023;14:15.
PubMed
Abstract available
Bladder only versus bladder plus pelvic lymph node chemoradiation for
muscle-invasive bladder cancer.
Urol Oncol. 2023 Jan 30:S1078-1439(22)00494.
PubMed
Abstract available
[Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration,
apoptosis and immune escape of endometrial carcinoma cells].
Zhonghua Zhong Liu Za Zhi. 2023;45:56-63.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by